155 related articles for article (PubMed ID: 27888617)
1. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice.
Lee SH; Park JW; Woo SH; Go DM; Kwon HJ; Jang JJ; Kim DY
Oncotarget; 2016 Dec; 7(52):87219-87231. PubMed ID: 27888617
[TBL] [Abstract][Full Text] [Related]
2. Ablation of osteopontin suppresses N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric cancer development in mice.
Lee SH; Park JW; Go DM; Kim HK; Kwon HJ; Han SU; Kim DY
Carcinogenesis; 2015 Dec; 36(12):1550-60. PubMed ID: 26438603
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin is involved in estrogen-mediated protection against diethylnitrosamine-induced liver injury in mice.
He C; Fan X; Chen R; Liang B; Cao L; Guo Y; Zhao J
Food Chem Toxicol; 2012 Aug; 50(8):2878-85. PubMed ID: 22609492
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
[TBL] [Abstract][Full Text] [Related]
5. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
6. Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression.
Kang YS; Jeong EJ; Seok HJ; Kim SK; Hwang JS; Choi ML; Jo DG; Kim Y; Choi J; Lee YJ; Jung E; Min JK; Han TS; Kim JS
Biochem Biophys Res Commun; 2019 Jan; 508(1):275-281. PubMed ID: 30497779
[TBL] [Abstract][Full Text] [Related]
7. Defective Initiation of Liver Regeneration in Osteopontin-Deficient Mice after Partial Hepatectomy due to Insufficient Activation of IL-6/Stat3 Pathway.
Wen Y; Feng D; Wu H; Liu W; Li H; Wang F; Xia Q; Gao WQ; Kong X
Int J Biol Sci; 2015; 11(10):1236-47. PubMed ID: 26327817
[TBL] [Abstract][Full Text] [Related]
8. Role of Hepatocyte-Derived Osteopontin in Liver Carcinogenesis.
Desert R; Ge X; Song Z; Han H; Lantvit D; Chen W; Das S; Athavale D; Abraham-Enachescu I; Blajszczak C; Chen Y; Musso O; Guzman G; Hoshida Y; Nieto N
Hepatol Commun; 2022 Apr; 6(4):692-709. PubMed ID: 34730871
[TBL] [Abstract][Full Text] [Related]
9. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells.
Im E; Yeo C; Lee EO
Life Sci; 2018 Sep; 209():259-266. PubMed ID: 30107166
[TBL] [Abstract][Full Text] [Related]
10. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis.
Fan X; He C; Jing W; Zhou X; Chen R; Cao L; Zhu M; Jia R; Wang H; Guo Y; Zhao J
Cancer Res; 2015 Jan; 75(1):86-97. PubMed ID: 25398438
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of β-Catenin in Mice.
Liu Y; Cao L; Chen R; Zhou X; Fan X; Liang Y; Jia R; Wang H; Liu G; Guo Y; Zhao J
Stem Cells; 2015 Dec; 33(12):3569-80. PubMed ID: 26033745
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines.
Chae S; Jun HO; Lee EG; Yang SJ; Lee DC; Jung JK; Park KC; Yeom YI; Kim KW
Int J Oncol; 2009 Dec; 35(6):1409-16. PubMed ID: 19885563
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin has a protective role in prostate tumor development in mice.
Danzaki K; Kanayama M; Alcazar O; Shinohara ML
Eur J Immunol; 2016 Nov; 46(11):2669-2678. PubMed ID: 27601131
[TBL] [Abstract][Full Text] [Related]
15. Fenofibrate suppresses the progression of hepatoma by downregulating osteopontin through inhibiting the PI3K/AKT/Twist pathway.
Chen W; Chen F; Gong M; Ye L; Weng D; Jin Z; Wang J
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1025-1035. PubMed ID: 37566308
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
17. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.
Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X
Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277
[TBL] [Abstract][Full Text] [Related]
18. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
19. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
